Taxanes in the Treatment of Head and Neck Squamous Cell Carcinoma

Taxanes in the Treatment of Head and Neck Squamous Cell Carcinoma

Taxanes, particularly docetaxel (DTX), has been widely used for combination therapy of head and neck squamous cell carcinoma (HNSCC). For locally advanced unresectable HNSCC, DTX combined with cisplatin and 5-fluorouracil as a revolutionary treatment revealed an advantage in the improvement of patie...

Full description

Bibliographic Details
Main Authors:	Ching-Yun Hsieh, Ching-Chan Lin, Wei-Chao Chang
Format:	Article
Language:	English
Published:	MDPI AG 2023-10-01
Series:	Biomedicines
Subjects:	head and neck squamous cell carcinoma (HNSCC) taxanes docetaxel (DTX) resistance
Online Access:	https://www.mdpi.com/2227-9059/11/11/2887

Similar Items

Efficacy and safety of cisplatin and weekly docetaxel in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
by: Moon Jin Kim, et al.
Published: (2019-09-01)

Head and neck malignant lymphoma and squamous cell carcinoma discernment, is DWI conclusive?
by: Dina Gameel Anis, et al.
Published: (2023-12-01)

The Role of Inflammation-Associated Factors in Head and Neck Squamous Cell Carcinoma
by: Li K, et al.
Published: (2023-09-01)

Real-world use of first-line pembrolizumab + platinum + taxane combination regimens in recurrent / metastatic head and neck squamous cell carcinoma
by: Christopher M. Black, et al.
Published: (2024-02-01)

Sarcopenia as a Prognostic Marker in Elderly Head and Neck Squamous Cell Carcinoma Patients Undergoing (Chemo-)Radiation
by: Erik Haehl, et al.
Published: (2022-11-01)

Clinical presentation and pattern of care for sarcomatoid variant of squamous cell carcinoma of the head-and-neck region: A retrospective study
by: Adhara Chakraborthy, et al.
Published: (2021-01-01)

Antitumor Efficacy of EGFR-Targeted Recombinant Immunotoxin in Human Head and Neck Squamous Cell Carcinoma
by: Guiqin Xie, et al.
Published: (2022-03-01)

Successful Treatment with Taxane-Based Chemotherapy in Advanced Sebaceous Carcinoma: A Case Report and Literature Review
by: Shuji Ota, et al.
Published: (2019-01-01)

Effects of Human Papilloma Virus E6/E7 Oncoproteins on Genomic Structure in Head and Neck Squamous Cell Carcinoma
by: Matthew Uzelac, et al.
Published: (2022-12-01)

HIF-1α or HOTTIP/CTCF Promotes Head and Neck Squamous Cell Carcinoma Progression and Drug Resistance by Targeting HOXA9
by: Qiang Sun, et al.
Published: (2020-06-01)

The Role of Immune Modulatory Cytokines in the Tumor Microenvironments of Head and Neck Squamous Cell Carcinomas
by: Nobuo Kondoh, et al.
Published: (2022-06-01)

Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma
by: Yangyang She, et al.
Published: (2020-01-01)

Development and validation of a nomogram to predict cervical lymph node metastasis in head and neck squamous cell carcinoma
by: Xiaohan Chen, et al.
Published: (2024-01-01)

Diagnostic and Therapeutic Applications of Exosomes in Cancer with a Special Focus on Head and Neck Squamous Cell Carcinoma (HNSCC)
by: Eliane Ebnoether, et al.
Published: (2020-06-01)

Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma: Identification, Characterization and Clinical Implications
by: Claudia Peitzsch, et al.
Published: (2019-05-01)

Emerging role of lncRNAs in drug resistance mechanisms in head and neck squamous cell carcinoma
by: José A. Peña-Flores, et al.
Published: (2022-08-01)

Understanding the Roles of the NSD Protein Methyltransferases in Head and Neck Squamous Cell Carcinoma
by: Madhavi Murali, et al.
Published: (2022-11-01)

Systemic Analysis of RNA Alternative Splicing Signals Related to the Prognosis for Head and Neck Squamous Cell Carcinoma
by: Zhexuan Li, et al.
Published: (2020-02-01)

Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma
by: Ming-Huei Chou, et al.
Published: (2021-03-01)

Expression of 3q Oncogene SEC62 Predicts Survival in Head and Neck Squamous Cell Carcinoma Patients Treated with Primary Chemoradiation
by: Maximilian Linxweiler, et al.
Published: (2023-12-01)

A Ferroptosis-Related Gene Signature for Predicting the Prognosis and Drug Sensitivity of Head and Neck Squamous Cell Carcinoma
by: Wei Lu, et al.
Published: (2021-10-01)

Role of Microenvironmental Components in Head and Neck Squamous Cell Carcinoma
by: Enar Jumaniyazova, et al.
Published: (2023-11-01)

A 14-Marker Multiplexed Imaging Panel for Prognostic Biomarkers and Tumor Heterogeneity in Head and Neck Squamous Cell Carcinoma
by: Junichi Mitsuda, et al.
Published: (2021-08-01)

Basaloid squamous cell carcinoma of the head and neck: Our experience
by: Jaimanti Bakshi, et al.
Published: (2020-01-01)

Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy
by: Habib Sadeghirad, et al.
Published: (2023-04-01)

Tumor Microenvironment in Head and Neck Squamous Cell Carcinomas
by: Görkem Eskiizmir
Published: (2015-09-01)

Taxanes in the Treatment of Advanced Gastric Cancer
by: Byung Woog Kang, et al.
Published: (2016-05-01)

Hypoxia-related LncRNAs signature predicts prognosis and is associated with immune infiltration and progress of head and neck squamous cell carcinoma
by: Minhan Li, et al.
Published: (2022-09-01)

Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway
by: Zejia Yang, et al.
Published: (2019-05-01)

Effects of the COVID-19 pandemic on elderly patients with head and neck squamous cell carcinoma
by: Pei-Jing Ye, et al.
Published: (2022-09-01)

Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma
by: Anna Brandt, et al.
Published: (2023-03-01)

Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
by: Ronan W. Hsieh, et al.
Published: (2021-09-01)

FTH1 indicates poor prognosis and promotes metastasis in head and neck squamous cell carcinoma
by: Qingyun Liao, et al.
Published: (2023-11-01)

Hypermethylation of PRKCZ Regulated by E6 Inhibits Invasion and EMT via Cdc42 in HPV-Related Head and Neck Squamous Cell Carcinoma
by: Hao-Fan Wang, et al.
Published: (2022-08-01)

Catulin Based Reporter System to Track and Characterize the Population of Invasive Cancer Cells in the Head and Neck Squamous Cell Carcinoma
by: Kamila Karpińska, et al.
Published: (2021-12-01)

Insight into Classification and Risk Stratification of Head and Neck Squamous Cell Carcinoma in Era of Emerging Biomarkers with Focus on Histopathologic Parameters
by: Antti A. Mäkitie, et al.
Published: (2022-11-01)

Cuproptosis-associated CDKN2A is targeted by plicamycin to regulate the microenvironment in patients with head and neck squamous cell carcinoma
by: Kaihui Fan, et al.
Published: (2023-01-01)

Taxane-induced morphea in a patient with CREST syndrome
by: Susan Michele Bouchard, et al.
Published: (2010-07-01)

PD-L1 Testing and Squamous Cell Carcinoma of the Head and Neck: A Multicenter Study on the Diagnostic Reproducibility of Different Protocols
by: Simona Crosta, et al.
Published: (2021-01-01)

DISEASE RECURRENCE PREDICTORS FOR PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA
by: Yuniardini S. Wimardhani, et al.
Published: (2015-06-01)